OMX Stockholm Pharmaceuticals a SX201030GI Indice
7062.38 SEK
{{ price }}
0.887046%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
7062.38
-
7062.38 SEK
Numero di componenti
32
OMX Stockholm Pharmaceuticals a Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| HNSA.ST | Hansa Biopharma AB (publ) | +6.78% | |
|---|---|---|---|
| ISOFOL.ST | Isofol Medical AB (publ) | +6.09% | |
| ACE.ST | Ascelia Pharma AB (publ) | +5.76% | |
| ACTI.ST | Active Biotech AB (publ) | +3.85% | |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | +3.69% |
Top 5 Perdenti delle Ultime 24 Ore
| EGTX.ST | Egetis Therapeutics AB (publ) | -1.86% | |
|---|---|---|---|
| IMMU.ST | Mendus AB (publ) | -1.74% | |
| MOB.ST | Moberg Pharma AB (publ) | -1.53% | |
| CANTA.ST | Cantargia AB (publ) | -1.04% | |
| ATORX.ST | Alligator Bioscience AB (publ) | -0.88% |
OMX Stockholm Pharmaceuticals a SX201030GI PANORAMICA FINANZIARIA E DI TRADING
| OMX Stockholm Pharmaceuticals a Prezzo dell'Indice | 7062.38 SEK |
| Chiusura Precedente | N/A |
| Apertura | N/A |
| Prezzo di Acquisto | N/A x N/A |
| Prezzo di Vendita | N/A x N/A |
| Variazione Giornaliera | N/A |
| Variazione a 52 Settimane | N/A |
| Volume | N/A |
| Volume Medio | N/A |
Informazioni di trading
OMX Stockholm Pharmaceuticals a Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | N/A |
| Minimo a 52 Settimane | N/A |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
SX201030GI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice OMX Stockholm Pharmaceuticals a
Qual è il prezzo attuale dell'Indice SX201030GI?
Il prezzo dell'Indice OMX Stockholm Pharmaceuticals a SX201030GI oggi è di 7062.38 SEK.
Come acquistare l'Indice OMX Stockholm Pharmaceuticals a?
Puoi acquistare l'indice SX201030GI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice OMX Stockholm Pharmaceuticals a?
La sigla (o ticker) dell'Indice OMX Stockholm Pharmaceuticals a è SX201030GI.
Quanti componenti contiene l'Indice OMX Stockholm Pharmaceuticals a?
L'Indice OMX Stockholm Pharmaceuticals a contiene 32 componenti.
A quale paese appartiene l'Indice OMX Stockholm Pharmaceuticals a?
L'Indice OMX Stockholm Pharmaceuticals a fa riferimento a United States.
A quale borsa appartiene l'Indice OMX Stockholm Pharmaceuticals a?
L'Indice OMX Stockholm Pharmaceuticals a fa riferimento alla borsa Nasdaq GIDS.
OMX Stockholm Pharmaceuticals a COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | $288 28.11 USD |
+0.7
|
$98.92B 9.66B USD | $123.59K 12.06K USD | $283.6 27.68 USD | $288.6 28.17 USD | $98.92B 9.66B USD | 25.17 | $11.44 1.12 USD |
| Camurus AB (publ) CAMX.ST | $645.5 63.01 USD |
+1.89
|
$38.36B 3.74B USD | $111.64K 10.9K USD | $629 61.4 USD | $647 63.16 USD | $38.36B 3.74B USD | 70.23 | $9.19 0.9 USD |
| Bonesupport Holding AB (publ) BONEX.ST | $289.2 28.23 USD |
+0.14
|
$19.05B 1.86B USD | $123.29K 12.04K USD | $281.4 27.47 USD | $290 28.31 USD | $19.05B 1.86B USD | 156.32 | $1.85 0.18 USD |
| BioArctic AB (publ) BIOA-B.ST | $185.9 18.15 USD |
+1.75
|
$16.46B 1.61B USD | $54.7K 5.34K USD | $180.1 17.58 USD | $186.3 18.19 USD | $16.46B 1.61B USD | 18.26 | $10.18 0.99 USD |
| Biotage AB (publ) BIOT.ST | $143.4 14 USD |
+0.14
|
$11.48B 1.12B USD | $22.59K 2.2K USD | $143.1 13.97 USD | $143.9 14.05 USD | $11.48B 1.12B USD | 45.09 | $3.18 0.31 USD |
| Calliditas Therapeutics AB (publ) CALTX.ST | $208 20.3 USD |
0
|
$11.24B 1.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.24B 1.1B USD | 0 | $0 0 USD |
| BioGaia AB (publ) BIOG-B.ST | $106.5 10.4 USD |
-0.19
|
$10.77B 1.05B USD | $60.38K 5.89K USD | $105.5 10.3 USD | $107.6 10.5 USD | $10.77B 1.05B USD | 34.80 | $3.06 0.3 USD |
| MedCap AB (publ) MCAP.ST | $486 47.44 USD |
+0.83
|
$7.26B 708.78M USD | $7.36K 718.62 USD | $476.5 46.51 USD | $490 47.83 USD | $7.26B 708.78M USD | 35.76 | $13.59 1.33 USD |
| Probi AB (publ) PROB.ST | $348 33.97 USD |
0
|
$3.97B 387.05M USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.97B 387.05M USD | 0 | $0 0 USD |
| BioInvent International AB (publ) BINV.ST | $36.35 3.55 USD |
+2.11
|
$2.39B 233.49M USD | $73.01K 7.13K USD | $35.1 3.43 USD | $36.6 3.57 USD | $2.39B 233.49M USD | 0 | -$7.12 -0.6 USD |
| Hansa Biopharma AB (publ) HNSA.ST | $28.04 2.74 USD |
+6.78
|
$2.31B 225.97M USD | $353.18K 34.47K USD | $26 2.54 USD | $28.32 2.76 USD | $2.31B 225.97M USD | 0 | -$9.25 -0.9 USD |
| Vicore Pharma Holding AB (publ) VICO.ST | $7.73 0.75 USD |
-0.51
|
$1.81B 177.02M USD | $139.12K 13.58K USD | $7.63 0.74 USD | $7.79 0.76 USD | $1.81B 177.02M USD | 0 | -$1.99 -0.1 USD |
| Xspray Pharma AB (publ) XSPRAY.ST | $48.3 4.71 USD |
+2.44
|
$1.79B 175.1M USD | $29.73K 2.9K USD | $46.35 4.52 USD | $49.35 4.82 USD | $1.79B 175.1M USD | 0 | -$7.59 -0.7 USD |
| Egetis Therapeutics AB (publ) EGTX.ST | $4.76 0.46 USD |
-1.86
|
$1.71B 166.91M USD | $191.41K 18.68K USD | $4.69 0.46 USD | $4.89 0.48 USD | $1.71B 166.91M USD | 0 | -$1 -0.09 USD |
| Saniona AB (publ) SANION.ST | $10.2 1 USD |
+0.59
|
$1.39B 135.5M USD | $255.44K 24.93K USD | $10 0.98 USD | $10.26 1 USD | $1.39B 135.5M USD | 5.09 | $2 0.2 USD |
| SynAct Pharma AB SYNACT.ST | $21.2 2.07 USD |
0
|
$1.04B 101.42M USD | $377.05K 36.8K USD | $19.96 1.95 USD | $22.3 2.18 USD | $1.04B 101.42M USD | 0 | -$1.89 -0.1 USD |
| Abliva AB (publ) ABLI.ST | $0.44 0.04 USD |
0
|
$715.67M 69.86M USD | $0 0 USD | $0 0 USD | $0 0 USD | $715.67M 69.86M USD | 0 | $0 0 USD |
| Orexo AB (publ) ORX.ST | $20.1 1.96 USD |
-0.25
|
$693.55M 67.7M USD | $14.45K 1.41K USD | $19.1 1.86 USD | $20.15 1.97 USD | $693.55M 67.7M USD | 0 | -$6.09 -0.5 USD |
| Infant Bacterial Therapeutics AB (publ) IBT-B.ST | $49.2 4.8 USD |
+3.69
|
$662.79M 64.7M USD | $5.22K 509.34 USD | $47.2 4.61 USD | $49.2 4.8 USD | $662.79M 64.7M USD | 0 | -$9.34 -0.9 USD |
| Ascelia Pharma AB (publ) ACE.ST | $4.5 0.44 USD |
+5.76
|
$432.48M 42.22M USD | $1.41M 137.43K USD | $4.15 0.4 USD | $4.6 0.45 USD | $432.48M 42.22M USD | 0 | -$1.22 -0.1 USD |
- {{ link.label }} {{link}}